Previous studies have also demonstrated that AF in diabetic rats induced by thiazolidinediones was associated with activation of the NF-κB pathway, leading to a pro-inflammatory state, myocardial hypertrophy, and fibrosis (58). This evidence concerns the gene NFKB1 and atrial fibrillation.